NEA Management Company as of March 31, 2016
Portfolio Holdings for NEA Management Company
NEA Management Company holds 37 positions in its portfolio as reported in the March 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Tesaro | 30.0 | $452M | 10M | 44.03 | |
| Groupon | 11.7 | $176M | 44M | 3.99 | |
| Ardelyx (ARDX) | 6.1 | $92M | 12M | 7.77 | |
| Adaptimmune Therapeutics (ADAP) | 5.3 | $80M | 9.9M | 8.13 | |
| Epizyme | 5.0 | $76M | 6.3M | 12.12 | |
| Senseonics Hldgs (SENS) | 5.0 | $75M | 26M | 2.86 | |
| Dermira | 4.8 | $73M | 3.5M | 20.68 | |
| Opower | 4.1 | $61M | 9.0M | 6.81 | |
| Glycomimetics (GLYC) | 3.4 | $51M | 8.6M | 5.96 | |
| Loxo Oncology | 3.2 | $49M | 1.8M | 27.34 | |
| Nevro (NVRO) | 2.5 | $37M | 660k | 56.26 | |
| Trevena | 2.1 | $32M | 3.8M | 8.27 | |
| Proteostasis Therapeutics In | 2.0 | $30M | 3.1M | 9.64 | |
| Lexicon Pharmaceuticals (LXRX) | 1.9 | $29M | 2.4M | 11.95 | |
| Aerohive Networks | 1.6 | $23M | 4.7M | 4.99 | |
| Clovis Oncology | 1.4 | $22M | 1.1M | 19.20 | |
| Endologix | 1.4 | $21M | 2.5M | 8.36 | |
| Care | 1.3 | $20M | 3.3M | 6.15 | |
| Tracon Pharmaceuticals | 0.9 | $13M | 1.9M | 6.99 | |
| Mirna Therapeutics | 0.9 | $13M | 3.0M | 4.37 | |
| Strongbridge Bioph shs usd | 0.7 | $9.8M | 2.1M | 4.56 | |
| Exelixis (EXEL) | 0.6 | $8.8M | 2.2M | 4.00 | |
| Zhone Technologies | 0.5 | $7.7M | 4.8M | 1.60 | |
| Aurinia Pharmaceuticals (AUPH) | 0.5 | $7.4M | 2.5M | 2.91 | |
| Rigel Pharmaceuticals | 0.5 | $6.7M | 3.2M | 2.08 | |
| Akari Therapeutics | 0.4 | $6.1M | 439k | 14.00 | |
| Champions Oncology (CSBR) | 0.4 | $5.7M | 1.6M | 3.64 | |
| Arca Biopharma | 0.3 | $5.1M | 1.5M | 3.47 | |
| Zosano Pharma | 0.3 | $5.0M | 2.2M | 2.30 | |
| Sunesis Pharmaceuticals | 0.3 | $4.2M | 7.8M | 0.54 | |
| ArQule | 0.3 | $4.0M | 2.5M | 1.60 | |
| Roka Bioscience | 0.1 | $2.2M | 3.2M | 0.69 | |
| Cerecor | 0.1 | $2.2M | 595k | 3.73 | |
| Orexigen Therapeutics | 0.1 | $2.1M | 3.7M | 0.56 | |
| Paratek Pharmaceuticals | 0.1 | $1.9M | 125k | 15.17 | |
| Catalyst Biosciences | 0.1 | $1.1M | 652k | 1.68 | |
| Agile Therapeutics | 0.1 | $829k | 134k | 6.21 |
